Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Artemio M. Jongco is active.

Publication


Featured researches published by Artemio M. Jongco.


Journal of Clinical Immunology | 2017

Immunodeficiencies Associated with Abnormal Newborn Screening for T Cell and B Cell Lymphopenia

Soma Jyonouchi; Artemio M. Jongco; Jennifer M. Puck; Kathleen E. Sullivan

Newborn screening for SCID has revealed the association of low T cells with a number of unexpected syndromes associated with low T cells, some of which were not appreciated to have this feature. This review will discuss diagnostic approaches and the features of some of the syndromes likely to be encountered following newborn screening for immune deficiencies.


Annals of Allergy Asthma & Immunology | 2014

X-linked agammaglobulinemia presenting as polymicrobial pneumonia, including Pneumocystis jirovecii

Artemio M. Jongco; Jonathan D. Gough; Kyle Sarnataro; David W. Rosenthal; Joanne Moreau; Punita Ponda; Vincent R. Bonagura

Pneumocystis jirovecii pneumonia is an opportunistic pulmonary infection usually associated with T-cell defects. Clinical and murine studies demonstrate that B-cells and Pneumocystis-specific antibodies also contribute to effective immune responses.1 Patients with primary humoral immunodeficiencies, including X-linked agammaglobulinemia (XLA), may develop P . jirovecii pneumonia despite normal T-cell number and function.2,3 XLA arises from Bruton tyrosine kinase (BTK) gene mutations, leading to pre-B-cell differentiation arrest, absence of immunoglobulin expression, and increased susceptibility to bacterial/enteroviral infections.4 Although more than 600 BTK mutations have been described, new variations/mutations continue to be identified. We describe an infant with a novel BTK kinase domain variation who presented with polymicrobial pneumonia, including P. jirovecii.


Journal of Clinical Immunology | 2016

The Importance of Measuring IL10 Levels in Patients with Suspected IL10/IL10R Defects

Susanne LaBarba; Benjamin Sahn; Erik Glocker; Bianca Eisele; Artemio M. Jongco; Vincent R. Bonagura

To the Editor: Interleukin 10 (IL-10) is an anti-inflammatory cytokine that is critical tomaintain immune homeostasis in the gastrointestinal tract. Its immunosuppressive effects include the restriction of T cell proliferation, limitation of pro-inflammatory cytokine production, and the downregulation of co-stimulatory protein expression on antigen presenting cells [1]. IL-10 signaling occurs through a heterotetrameric IL-10 receptor (IL10R) complex comprised of IL-10R1 and IL-10R2. IL-10 receptor deficiency is a rare primary immunodeficiency that typically presents early in life with inflammatory bowel disease, folliculitis, multiple abscesses, perianal fistulas, arthritis, and recurrent respiratory diseases [1]. This is caused by loss-of-function mutations in the genes encoding for the IL-10 receptor (IL10R) [2]. The histopathology of affected individuals demonstrates intestinal mucosa ulcers with epithelial inflammatory infiltrates and abscesses. Patients with IL10 deficiency often have minor immunologic abnormalities, including normal or slightly decreased serum immunoglobulin levels, decreased CD4+/CD8+ T cell ratios, and variations in T cell, B cell, and NK cell numbers. Individuals with IL-10 or IL-10R deficiency are typically unresponsive to immunosuppressive therapy. The only known treatment that is curative in these patients is hematopoietic stem cell transplantation (HSCT) [3]. To our knowledge, assessing serum IL-10 levels to attribute a potential signaling defect to the IL-10 receptor has not been previously described in children with IL-10R mutations. This paper describes a patient with IL-10R deficiency that was found to have a high serum IL-10 level as part of his initial immunological evaluation, raising suspicion for the eventual diagnosis of IL-10 receptor deficiency. A 4-year-old Turkish male, the product of a first-cousin consanguineous marriage, with a past medical history of partial central diabetes insipidus, cortical blindness, and global developmental delay, was initially seen in our Allergy clinic at the age of 1 year old with a diagnosis of milk protein proctocolitis secondary to the detection of blood in his stool. The patient subsequently failed an oral challenge to milk and was diagnosed with non-IgE-mediated milk allergy with a negative Immunocap at that time. He remained well on a milk-free diet for the next 2 years. At the age of 3 years, he was hospitalized with oral aphthous ulcers, persistent diarrhea with intermittent hematochezia, perirectal fissures and ulcerations. Gastrointestinal evaluation included an upper endoscopy that revealed aphthous ulcers in the esophagus and duodenum, and a colonoscopy revealed deep ulcers and friable mucosa throughout the colon. Mucosal histology demonstrated acute esophagitis, and focal areas of active ileitis and colitis. He was given a diagnosis of inflammatory bowel disease (IBD) and was placed on an elemental formula diet, antimicrobial therapy and topical steroids for the perirectal disease. He was evaluated in our Immunology clinic and a subsequent workup revealed normal quantitative immunoglobulins, T cell numbers and subpopulations and dihydrorhodamine (DHR) assay that ruled out chronic granulomatous disease. He also had a normal level of glucose 6-phosphate dehydrogenase, a positive * Susanne LaBarba [email protected]


Journal of Allergy | 2016

A Simple Allergist-Led Intervention Improves Resident Training in Anaphylaxis

Artemio M. Jongco; Sheila Bina; Robert Sporter; Marie A. Cavuoto Petrizzo; Blanka M. Kaplan; Myriam Kline; Susan J. Schuval


The Journal of Allergy and Clinical Immunology | 2018

Atopic Disease As A Prediction Of Metal Hypersensitivity In Pectus Excavatum Patients

Charmi Patel; Laura Helfner; Sherry Farzan; Artemio M. Jongco; Blanka M. Kaplan; Punita Ponda; David W. Rosenthal


The Journal of Allergy and Clinical Immunology | 2018

Allergic and Immunologic Dysregulation in Ehlers-Danlos Syndrome: A Case Series

Alice S. Chau; Artemio M. Jongco


The Journal of Allergy and Clinical Immunology | 2018

Underutilization of Penicillin Skin Testing in the Outpatient Setting.

Omar Waqar; Artemio M. Jongco; Roxanne C. Oriel


Annals of Allergy Asthma & Immunology | 2017

P289 A case of Phosphoacetylglucosamine Mutase (PGM3) deficiency in a patient with CFTR-related metabolic syndrome (CRMS)

B. Navetta-Modrov; B. Kaplan; Artemio M. Jongco


The Journal of Allergy and Clinical Immunology | 2016

Teaching and Evaluating Residents' Epinephrine Autoinjector Use with the Epipen® Proficiency Assessment Tool (E-PAT)

Artemio M. Jongco; Scott J. Bodner; Ana Barrera; Joshua L. Brenner; Brianne Navetta-Modrov; Myriam Kline; Saima Chaudhry; Gregory Grimaldi; Barry Kanzer; Michal Tamuz


The Journal of Allergy and Clinical Immunology | 2016

Prevalence of Atopic Diseases in Patients with Humoral Primary Immunodeficiency: A Comparison of a Single Center and the US Immunodeficiency Network (USIDNET)

Alice S. Chau; Artemio M. Jongco; Laura Helfner; James C. Fagin; Vincent R. Bonagura

Collaboration


Dive into the Artemio M. Jongco's collaboration.

Top Co-Authors

Avatar

Vincent R. Bonagura

The Feinstein Institute for Medical Research

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Myriam Kline

The Feinstein Institute for Medical Research

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Ana Barrera

North Shore-LIJ Health System

View shared research outputs
Top Co-Authors

Avatar

Barry Kanzer

Long Island Jewish Medical Center

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge